An up-to-date anti-cancer treatment strategy focusing on HIF-1alpha suppression: its application for refractory ovarian cancer.
Fujita M, Yasuda M, Kitatani K, Miyazawa M, Hirabayashi K, Takekoshi S, Iida T, Hirasawa T, Murakami M, Mikami M, Ishiwata I, Shimizu M, Osamura RY.
Fujita M, et al. Among authors: kitatani k.
Acta Histochem Cytochem. 2007 Dec 18;40(5):139-42. doi: 10.1267/ahc.07024.
Acta Histochem Cytochem. 2007.
PMID: 18224245
Free PMC article.